Zachary Smith

3.3k total citations · 3 hit papers
71 papers, 1.5k citations indexed

About

Zachary Smith is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Zachary Smith has authored 71 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Infectious Diseases and 11 papers in Surgery. Recurrent topics in Zachary Smith's work include SARS-CoV-2 and COVID-19 Research (9 papers), Pulmonary Hypertension Research and Treatments (7 papers) and SARS-CoV-2 detection and testing (6 papers). Zachary Smith is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), Pulmonary Hypertension Research and Treatments (7 papers) and SARS-CoV-2 detection and testing (6 papers). Zachary Smith collaborates with scholars based in United States, United Kingdom and Sweden. Zachary Smith's co-authors include Amadea Britton, Katherine E. Fleming-Dutra, Emma K. Accorsi, Jennifer R. Verani, Nong Shang, Gordana Derado, Stephanie J. Schrag, Joseph D. Miller, Ruth Link‐Gelles and R. L. Smith and has published in prestigious journals such as Journal of the American Chemical Society, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Zachary Smith

60 papers receiving 1.5k citations

Hit Papers

Association Between 3 Doses of mRNA COVID-19 Vaccine and ... 2022 2026 2023 2024 2022 2024 2023 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
    2022 403 citations Emma K. Accorsi, Amadea Britton et al. profile →
  2. Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024
    2024 80 citations Ruth Link‐Gelles, Allison Avrich Ciesla et al. MMWR Morbidity and Mortality Weekly Report profile →
  3. Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023
    2023 76 citations Ruth Link‐Gelles, Allison Avrich Ciesla et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zachary Smith United States 17 808 304 219 150 147 71 1.5k
Doron Netzer Israel 12 941 1.2× 263 0.9× 217 1.0× 153 1.0× 202 1.4× 37 1.5k
Eric A. Coomes Canada 12 1.1k 1.4× 758 2.5× 73 0.3× 398 2.7× 229 1.6× 36 2.5k
Rachel Katz Israel 16 479 0.6× 173 0.6× 146 0.7× 41 0.3× 309 2.1× 32 1.5k
Hannah Chung Canada 14 825 1.0× 259 0.9× 240 1.1× 197 1.3× 100 0.7× 53 1.7k
David C. Klonoff United States 15 865 1.1× 114 0.4× 84 0.4× 225 1.5× 173 1.2× 28 1.8k
Simon Thelwall United Kingdom 9 1.9k 2.3× 608 2.0× 66 0.3× 174 1.2× 247 1.7× 19 2.4k
Yaling Hu China 10 1.5k 1.8× 478 1.6× 35 0.2× 158 1.1× 203 1.4× 21 1.7k
Young-Joon Park South Korea 18 387 0.5× 139 0.5× 63 0.3× 72 0.5× 89 0.6× 79 1.0k
Mohammad Zarei Iran 18 403 0.5× 157 0.5× 47 0.2× 85 0.6× 205 1.4× 37 1.2k
Zhen Chen China 17 822 1.0× 304 1.0× 24 0.1× 86 0.6× 184 1.3× 58 1.8k

Countries citing papers authored by Zachary Smith

Since Specialization
Citations

This map shows the geographic impact of Zachary Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zachary Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zachary Smith more than expected).

Fields of papers citing papers by Zachary Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zachary Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zachary Smith. The network helps show where Zachary Smith may publish in the future.

Co-authorship network of co-authors of Zachary Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Zachary Smith. A scholar is included among the top collaborators of Zachary Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zachary Smith. Zachary Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Zachary, et al.. (2025). Non-invasive Assessment of Coronary Artery Disease: The Role of AI in the Current Status and Future Directions. Cureus. 17(2). e78994–e78994. 1 indexed citations
2.
3.
Smith, Zachary, et al.. (2025). A qualitative examination of the evolving role of sports technology in collegiate coaching. Frontiers in Sports and Active Living. 7. 1644099–1644099. 1 indexed citations
4.
Smith, Zachary. (2024). Part II: Case series: Acute agitation, delirium, and sleep management. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(3). 305–326.
5.
Fleming-Dutra, Katherine E., Allison Avrich Ciesla, Lauren E. Roper, et al.. (2023). Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023. MMWR Morbidity and Mortality Weekly Report. 72(7). 177–182. 11 indexed citations
6.
7.
Link‐Gelles, Ruth, Allison Avrich Ciesla, Lauren E. Roper, et al.. (2023). Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023. MMWR Morbidity and Mortality Weekly Report. 72(5). 119–124. 76 indexed citations breakdown →
8.
Abdalla, Maha, et al.. (2023). Theophylline for the management of respiratory disorders in adults in the 21st century: A scoping review from the American College of Clinical Pharmacy Pulmonary Practice and Research Network. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(9). 963–990. 10 indexed citations
9.
Patel, Anand, et al.. (2023). Provision of ambrisentan from a health-system specialty pharmacy affiliated with a pulmonary hypertension Center of Comprehensive Care. American Journal of Health-System Pharmacy. 81(2). 66–73.
10.
Huskinson, Sally L., Donna M. Platt, Zachary Smith, et al.. (2023). Quantification of observable behaviors following oral administration of oxycodone and nalfurafine in male rhesus monkeys. Drug and Alcohol Dependence. 252. 110953–110953. 4 indexed citations
11.
Murphy, Kristin, et al.. (2021). Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation. BMC Cancer. 21(1). 1342–1342. 6 indexed citations
12.
Elkbuli, Adel, et al.. (2020). Mild and Moderate Traumatic Brain Injury and Gender‐Based Critical Care Outcomes. World Journal of Surgery. 44(5). 1492–1497. 5 indexed citations
13.
Smith, Zachary, et al.. (2020). Argatroban dosing requirements in extracorporeal life support and other critically ill populations. Thrombosis Research. 189. 69–76. 12 indexed citations
14.
Elkbuli, Adel, et al.. (2019). Thoracic Endovascular Aortic Repair Versus Open Repair: Analysis of the National Trauma Data Bank. Journal of Surgical Research. 245. 179–182. 19 indexed citations
15.
Smith, Zachary, et al.. (2019). Medication‐Induced Hyperlactatemia and Lactic Acidosis: A Systematic Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 39(9). 946–963. 39 indexed citations
16.
Solomon, Robert, et al.. (2019). HEMODYNAMIC EFFECTS OF SILDENAFIL ON RIGHT HEART FUNCTION IN LEFT VENTRICULAR DEVICES. Journal of the American College of Cardiology. 73(9). 831–831. 3 indexed citations
17.
Marin, Zach, et al.. (2016). Computational growth model of breast microcalcification clusters in simulated mammographic environments. Computers in Biology and Medicine. 76. 7–13. 8 indexed citations
18.
Smith, Zachary, et al.. (2016). Treatment of patients with chronic thrombo­embolic pulmonary hypertension: focus on riociguat. Therapeutics and Clinical Risk Management. 12. 957–957. 6 indexed citations
19.
Pinelli, Nicole R., et al.. (2010). Effect of Administration Time of Exenatide on Satiety Responses, Blood Glucose, and Adverse Events in Healthy Volunteers. The Journal of Clinical Pharmacology. 51(2). 165–172. 17 indexed citations
20.
Bittman, Robert, et al.. (1990). Synthesis and antineoplastic properties of ether-linked thioglycolipids. Journal of Medicinal Chemistry. 33(9). 2614–2621. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doron Netzer Breakdown of academic impact, for papers by Eric A. Coomes Breakdown of academic impact, for papers by Rachel Katz Breakdown of academic impact, for papers by Hannah Chung Breakdown of academic impact, for papers by David C. Klonoff Breakdown of academic impact, for papers by Simon Thelwall Breakdown of academic impact, for papers by Yaling Hu Breakdown of academic impact, for papers by Young-Joon Park Breakdown of academic impact, for papers by Mohammad Zarei Breakdown of academic impact, for papers by Zhen Chen
Rankless by CCL
2026